Stock listing
A40A1Q Stock Price, News, Filings & Events — Argent Biopharma Ltd
Selected listing: A40A1Q · LS · EUR · DE
This page tracks Argent Biopharma Ltd's A40A1Q:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40A1Q:LS. A40A1Q:LS is the stock-level entry point for investors researching Argent Biopharma Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A40A1Q:LS
- Asset type
- Stock
- Market cap
- $2.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- LS
- Currency
- EUR
Argent Biopharma Ltd A40A1Q:LS stock context
This page tracks Argent Biopharma Ltd's A40A1Q:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40A1Q:LS. A40A1Q:LS is the stock-level entry point for investors researching Argent Biopharma Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Argent Biopharma Ltd
Appendix 4E and 2026 Annual Report
August 31, 2026
FDA-CVM Establish INAD File for CannEpil Veterinary Program
August 25, 2026
US Veterinary Development Programme for CannEpil Commences
August 5, 2026
CannEpil Global Licence Expands into Veterinary Healthcare
July 30, 2026
RGT Executes Global CannEpil Licensing Deal for US$5.5M
July 6, 2026
Research Argent Biopharma Ltd
Argent Biopharma Ltd investor report
Review AI stock analysis and investor report context for A40A1Q:LS.
Argent Biopharma Ltd company profile
View the public company page for Argent Biopharma Ltd on 6ix.
Argent Biopharma Ltd news
Read company news and market updates connected to Argent Biopharma Ltd.
Argent Biopharma Ltd investor events
Find investor webinars, events, and replay context for Argent Biopharma Ltd.
Alternate listings
RGT:ASX
AU · AUD
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
RGTLF:OTC
US · USD
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
A2ACB6:LSX
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
A40A1Q:LSX
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
H5O0:GETTEX
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
H5O0:DUS
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
H5O0:FWB
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
A2ACB6:LS
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.
H5O0:SWB
DE · EUR
Alternate listing for Argent Biopharma Ltd; the primary context on this page is A40A1Q:LS.